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OBJECTIVES The purpose of this study was to evaluate whether higher coronary blood flow, estimated by
the corrected Thrombolysis In Myocardial Infarction (TIMI) frame count (CTFC), is related
to better functional and clinical outcome after successful percutaneous transluminal coronary
angioplasty (PTCA) in patients with acute myocardial infarction (AMI).
BACKGROUND Experimental studies have found that functional recovery of the infarcted myocardium was
associated with increased blood flow (reactive hyperemia) to the infarcted bed shortly after
reperfusion.
METHODS We measured CTFC immediately after successful (TIMI 3) primary PTCA in 104
consecutive patients with their first AMI. Wall motion score index (WMSI) and the presence
of pericardial effusion were assessed by two-dimensional echocardiography before and one
month after PTCA.
RESULTS The patients were divided into two groups according to mean CTFC for corresponding
coronary artery of the control group: TIMI 3 slow group (45 patients, 40 . CTFC $ 23) and
TIMI 3 fast group (59 patients, CTFC , 23). There were no significant differences in the
baseline characteristics and WMSI before reperfusion between the two groups. Improvement
of WMSI in the TIMI 3 fast group was significantly greater than that of the TIMI 3 slow
group (1.33 6 0.52 vs. 0.60 6 0.34, p , 0.001). Pericardial effusion and intractable heart
failure were observed more frequently in the TIMI 3 slow group than in the TIMI 3 fast
group (27 vs. 10%; p , 0.05, 36 vs. 17%; p , 0.05). Corrected TIMI frame count, assessed
as a continuous variable, had a significant correlation with the change in WMSI (r 5 0.60,
p , 0.001) after adjusting for age, gender, history of hypertension, history of diabetes, elapsed
time to PTCA, collateral grade, presence of antegrade flow before PTCA and number of
diseased vessels.
CONCLUSIONS Lower CTFC of the infarct-related artery immediately after PTCA was associated with
greater functional recovery; and hence, CTFC can predict clinical and functional outcome in
patients with successful PTCA. (J Am Coll Cardiol 2001;38:666–71) © 2001 by the
American College of Cardiology
The achievement of Thrombolysis In Myocardial Infarction
(TIMI) 3 flow in the infarct-related artery (IRA) is the
primary goal of reperfusion therapy in patients with acute
myocardial infarction (AMI). Percutaneous transluminal
coronary angioplasty (PTCA) has been widely performed
because of better recanalization rate and less residual steno-
sis compared with thrombolytic therapy (1–4). However,
myocardial tissue perfusion may remain impaired even after
the achievement of TIMI 3 flow of the IRA without
residual stenosis. The failure to achieve adequate tissue
perfusion is referred to as the “no-reflow” or “low-reflow”
phenomenon and is established at the time of reperfusion
due to microcirculatory damage induced by ischemia (5–10).
The corrected TIMI frame count (CTFC) is a simple
clinical tool for assessing quantitative indexes of coronary
blood flow. This technique counts the number of cinean-
giographic frames from initial contrast opacification of the
proximal coronary artery to opacification of distal arterial
landmarks and is corrected for the length of left anterior
descending coronary artery (LAD) (11,12). Although
CTFC has been reported to be more accurate in predicting
outcome of thrombolytic therapy after AMI (13), no study
has examined the relationship between CTFC immediately
after successful PTCA (TIMI 3) or clinical outcome in
patients with AMI. Therefore, we evaluated CTFC after
primary PTCA as a predictor of functional recovery and
clinical outcome in patients with AMI.
METHODS
Study population. The study group consisted of 104 con-
secutive patients who were admitted to the coronary care
unit of Kansai Medical University with their first AMI and
who underwent revascularization within 12 h of onset by
primary PTCA. Patients were selected on the following
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criteria: 1) ,50% diameter stenosis with TIMI 3 flow of the
IRA after primary PTCA; 2) no evidence of reinfarction
during a one month follow-up period with enough good
patency of the culprit lesion (IRA , 75% diameter stenosis)
at follow-up angiography; and 3) adequate echocardio-
graphic imaging quality. The diagnosis of AMI was based
on chest pain lasting .30 min, persistent ST-segment
elevation .0.1 mV in two or more contiguous leads on the
12-lead electrocardiogram (ECG) and increase in the serum
creatine phosphokinase (CPK) levels with .5% MB frac-
tion. The study protocol was approved by the Institutional
Ethics Committee on Human Research, and informed
consent was obtained from all patients.
Treatment regimen. All patients were given aspirin
(81 mg) and 3,000 U of intravenous heparin just after
diagnosis of AMI. Two-dimensional echocardiographic im-
ages were obtained before reperfusion and at a mean of 27
days after the onset of AMI with a commercially available
echocardiographic system equipped with a sector transducer
(Sonos 2500, 5500 Agilent Technologies, Palo Alto, Cali-
fornia). Parasternal long-axis, short-axis, apical two- and
four-chamber views were recorded on S-VHS videotapes
for later analysis. Primary PTCA was performed by con-
ventional technique using the femoral approach. After
arterial cannulation, all patients received heparin (7,000 IU)
and isosorbide dinitrate (2 mg). After a 7F guiding catheter
was positioned in the ostium of the coronary artery, baseline
angiography was performed. Coronary flow of the IRA
before and after PTCA was graded visually according to the
TIMI Study group flow classification (14). Collateral flow
before PTCA was graded visually using a classification by
Rentrop et al. (15). Grade 0 collateral flow was defined as
the absence of visible collaterals, grade 1 flow as the filling
of side branches only, grade 2 flow as the filling of side
branches and a portion of the main epicardial artery and
grade 3 flow as complete filling of the side branches and
epicardial vessel beyond the point of the occlusion. Ade-
quate collateral was considered present when the collateral
flow was graded 2 or 3. Subsequently, primary PTCA was
performed using standard balloon dilation catheters, rang-
ing in diameter from 2.0 mm to 4.0 mm, chosen according
to the size of vascular regions adjacent to the stenosis.
Angioplasty success was defined as ,50% diameter stenosis
with TIMI 3 flow (CTFC ,40) of the IRA after primary
PTCA. Adjunct stentings were performed in cases with
$50% diameter stenosis. After achievement of TIMI 3 flow
of IRA, coronary angiography was performed to measure
CTFC after administration of isosorbide dinitrate (2 mg).
Coronary angiography was repeated at one month after the
onset of AMI to confirm the patency of IRA.
Echocardiographic data. Echocardiographic images on
admission (baseline) were used to assess the initial extent of
left ventricular (LV) dysfunction. Follow-up image at one
month after the onset of AMI was paired with the corre-
sponding baseline image and directly compared to assess the
change in regional wall motion. A semiquantitative scoring
system was used to analyze each study. The LV was divided
into 16 segments: short-axis slice at the levels of the mitral
valve and midpapillary muscle divided into six segments.
The apex of the LV was divided into four segments. Wall
motion in each segment was evaluated as follows: 3,
akinetic/dyskinetic; 2, severely hypokinetic; 1, hypokinetic;
0, normal. Wall motion score index (WMSI) was calculated
as the mean score of the segments showing asynergy at
baseline, and improvement of wall motion was calculated as
the change in WMSI (DWMSI before primary PTCA 2
one month). The presence of pericardial effusion was
assessed at one month with the method described by
Horowitz et al. (16). An epicardial-pericardial separation
that persisted throughout the cardiac cycle (D pattern) was
considered diagnostic of pericardial effusion (16). Wall
motion score index and pericardial effusion were determined
by two independent observers who had no knowledge of the
clinical and angiographic data. In cases of disagreement,
consensus was established with a third observer.
TIMI frame count. Thrombolysis in Myocardial Infarc-
tion frame count was defined as the number of frames
required for dye to first opacify a standard distal landmark.
The TIMI frame of the coronary artery was obtained using
the technique described by Gibson et al. (11). The TIMI
frame count was measured with digital cardiac image
sequence acquisitions (Advantx LC and DLX, GE Medical
Systems, Chicago, Illinois) that were displayed and stored in
a 512 matrix of simultaneously recorded images on the
standard cine films. Live digital cardiac acquisitions can be
closely compared to cineradiography. The important dis-
tinction between cine and live digital cardiac acquisitions is
that digital cardiac acquisitions have an ability to perform
optimal quantitative analysis measurements on live images
(17). The frame rate of a digital cardiac image was calcu-
lated as 30 frames/s. The TIMI frame counts of 60
consecutive angiographically normal coronary arteries free
of ischemic syndrome in our facility were obtained to
determine the normal CTFC. The mean CTFC value
obtained from these subjects was 23. Therefore, a cutoff
point of 23 was used to divide TIMI fast versus slow. To
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correct the longer length of LAD from right coronary
artery (RCA) or left circumflex coronary artery (LCX),
the TIMI frame count of the LAD was divided by
unadjusted TIMI frame count of the normal LAD,
divided by the mean TIMI frame count of the RCA and
LCX, yielding a CTFC. A CTFC was calculated by
dividing the LADs’ TIMI frame counts by 1.7 to normalize
for their longer lengths in accordance with standard meth-
ods (11). A CTFC of 40 has previously been identified as
the cutpoint for distinguishing TIMI flow grade 3 versus 2
(11). By definition, all the patients in this study restored
TIMI 3 flow of the culprit vessel after intervention
(CTFC , 40). Assessment of CTFC and TIMI flow grade
was made by two experienced observers blinded to other
clinical data. Disagreement was resolved by a third observer.
Intra-observer reproducibility was 2.9 6 1.6 frames. Inter-
observer variability was 3.2 6 1.75 frames.
Quantitative angiographic analysis. Quantitative angio-
graphic analysis was performed after angioplasty and at
follow-up in matched views using an online system (QCA-
QVA System, GE Medical System, Chicago, Illinois).
Measurement was made with the use of a validated edge-
detection algorithm. The following parameters were calcu-
lated as the mean values from two orthogonal views:
reference diameter, minimal lumen diameter and percent
diameter stenosis, respectively.
Definition of LV heart failure. Left ventricular heart
failure was defined as the presence of clinical congestive
heart failure (the presence of a third heart sound, Killip class
$2, Forrester subsets of 2 or 4, dyspnea or evidence of
pulmonary congestion on chest radiographs).
Statistical analysis. Results are expressed as mean 6 SD.
Comparisons between continuous variables were performed
using Student t test or Mann-Whitney U test where
applicable. Categorical variables were compared using
Fisher exact probability test. Univariate linear regression
analysis was used to assess the relation between CTFC and
DWMSI. Stepwise linear regression analysis (selection cri-
terion p , 0.20) was performed to assess the important
factors related to DWMSI using nine clinical variables: age,
gender, history of hypertension, history of diabetes, elapsed
time to PTCA, collateral grade, presence of antegrade flow
before PTCA, number of diseased vessels and CTFC. For
all analysis, a p value ,0.05 was considered significant.
RESULTS
Baseline characteristics. The mean TIMI frame counts of
60 angiographically normal coronary arteries were LAD:
38.6 6 3.0, LCX: 23.6 6 2.9 and RCA: 22.5 6 3.1. The
ratio of the TIMI frame count between LAD and RCA or
LCX was 1.7, which was concordant with a previous report
(11). The mean CTFC was 23 6 3 in an angiographically
normal coronary artery. Patients were divided into two
groups according to mean CTFC of the corresponding
coronary artery in the control group: 45 patients with 40 .
CTFC $ 23 (TIMI 3 slow group) and 59 patients with
CTFC , 23 (TIMI 3 fast group).
Baseline clinical characteristics are shown in Table 1.
There were no significant differences between the two
groups with regard to age, gender, peak CPK, LAD culprit
location, collateral grade, incidence of coronary risk factors
and single-vessel disease and TIMI flow grade before
reperfusion. The blood pressure and heart rate were similar
between the two groups. However, elapsed time from the
onset of symptoms to reperfusion in the TIMI slow group
was significantly longer than that of the TIMI fast group.
Coronary stents were implanted in 12 patients in the TIMI
slow group and in 17 patients in the TIMI fast group (p 5
0.829).
Quantitative angiographic analysis. The angiographic
measurements immediately and one month after PTCA are
summarized in Table 2. Although the diameter stenosis of
the TIMI 3 slow group tended to be smaller than that of the
TIMI fast group, reference vessel diameter and minimal
lumen diameter were similar between the two groups







Men (%) 35 (78) 40 (68) 0.280
Age (yr) 61 6 12 62 6 12 0.590
Mean blood pressure (mm Hg) 103 6 20 102 6 24 0.698
Heart rate (beats/min) 77 6 16 76 6 14 0.657
Risk factors
Hypertension (%) 20 (44) 26 (44) 0.999
Diabetes mellitus (%) 19 (42) 18 (31) 0.224
LAD culprit location (%) 21 (47) 31 (53) 0.693
Location of culprit lesions
LAD (segment 6/7) 16/5 20/11 0.542
RCA (segment 1, 2/3) 10/7 18/5 0.296
LCX (segment 11/13) 3/4 2/3 0.990
Single-vessel disease (%) 32 (71) 31 (53) 0.069
Stent (%) 12 (27) 17 (29) 0.829
Elapsed time (h)* 5.8 6 2.6 4.7 6 2.4 0.041
Peak CPK (IU) 4,050 6 2,455 3,453 6 2,100 0.201
Collateral (grade $ 2) (%) 7 (16) 15 (25) 0.333
CTFC (frames) 31.3 6 5.7 16.3 6 3.6 ,0.001
TIMI before PTCA (0/1/2) 33/6/6 32/15/12 0.131
*Elapsed time was defined as symptom onset to reperfusion
CPK 5 creatine phosphokinase; CTFC 5 corrected TIMI frame count; LAD 5
left anterior descending coronary artery; LCX 5 left circumflex coronary artery;
PTCA 5 percutaneous transluminal coronary angioplasty; RCA 5 right coronary
artery; TIMI 5 Thrombolysis In Myocardial Infarction.







Reference vessel diameter (mm) 3.2 6 0.7 3.1 6 0.5 0.720
Diameter stenosis (%)
Immediately after PTCA 22 6 13 26 6 10 0.084
One month after PTCA 38 6 16 40 6 15 0.610
Minimal lumen diameter (mm)
Immediately after PTCA 2.4 6 0.5 2.3 6 0.5 0.240
One month after PTCA 2.0 6 0.7 1.9 6 0.6 0.480
PTCA 5 percutaneous transluminal coronary angioplasty; TIMI 5 Thrombolysis In
Myocardial Infarction.
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immediately after PTCA. There were no significant differ-
ences between the two groups with regard to diameter
stenosis, reference vessel diameter and minimal lumen
diameter one month after PTCA.
Echocardiographic WMSI. Figure 1 shows the change in
WMSI from admission to one month. There was no
significant difference in WMSI on admission between the
two groups (TIMI 3 slow group; 2.91 6 0.76 vs. TIMI 3
fast group; 2.82 6 0.47, p 5 0.48). The WMSI significantly
improved at one month in both groups, but the DWMSI in
the TIMI 3 fast group was significantly larger than that of
the TIMI 3 slow group (1.33 6 0.52 vs. 0.60 6 0.34, p ,
0.001). Pericardial effusion and LV heart failure were
observed more frequently in the TIMI 3 slow group than in
the TIMI 3 fast group (Table 3).
Predictors of DWMSI. The relationship between
DWMSI and CTFC is presented in Figure 2. There was a
significant negative correlation between DWMSI and
CTFC (r 5 20.602, p , 0.001). When stepwise linear
regression analysis was performed to evaluate the important
factor, related DWMSI, lower CTFC, shorter elapsed time
and presence of antegrade flow before PTCA were the
significant factors related to DWMSI after adjustment for
age, gender, history of diabetes, history of hypertension,
collateral grade and number of diseased vessels (Table 4).
DISCUSSION
The major finding of this study was that lower CTFC
(faster coronary flow of IRA) in patients with TIMI 3
immediately after primary PTCA was associated with
greater functional recovery and lower incidence of compli-
cations in the convalescent stage compared with those with
higher CTFC. Moreover, lower CTFC immediately after
primary PTCA was found to be the most powerful predictor
for improvement of regional LV function by multivariate
analysis.
Assessment of microvascular perfusion by intracoronary
myocardial contrast echocardiography (7), positron emis-
sion tomography (8), radionuclide imaging (9) and Doppler
guide wire (10) have revealed the no-reflow phenomenon in
patients with TIMI 3 flow of the IRA. Because the
no-reflow or low-reflow phenomenon was associated with
poor functional recovery and adverse clinical events, many
cardiologists have focused on microvascular reperfusion of
infarcted myocardium as a final goal of reperfusion therapy.
However, these modalities have not found widespread
application for the assessment of microvascular perfusion,
because of the demanding nature of the technique, high
cost, time-consuming or not readily available in all coronary
laboratories. Recently, CTFC has been proposed as a
simple, inexpensive, reproducible and quantitative method
to assess coronary blood flow (11). In this study, we
measured CTFC from the digital angiographic recording
system and found that CTFC can discriminate individual
patients with poor functional recovery and adverse clinical
events from those with favorable outcome in the catheter-
ization laboratory at the time of reperfusion.
Previous studies. Gibson et al. (13) reported that higher
CTFC 90 min after thrombolytic therapy was related to
Figure 1. The change in WMSI from admission to one month. The
DWMSI is significantly larger in the TIMI 3 fast group than in the
TIMI 3 slow group. TIMI 5 Thrombolysis In Myocardial Infarction;
DWMSI 5 absolute change in the wall motion score index.
Figure 2. The relation between corrected TIMI frame count (CTFC) and
DWMSI in patients with acute myocardial infarction. The CTFC corre-
lated positively with DWMSI in the range of CTFC ,40. Abbreviations
as in Figure 1.





(n 5 59) p Value
Pericardial effusion (%) 12 (27) 6 (10) 0.037
Congestive heart failure(%) 16 (36) 10 (17) 0.040
TIMI 5 Thrombolysis In Myocardial Infarction.
669JACC Vol. 38, No. 3, 2001 Hamada et al.
September 2001:666–71 TIMI Frame Count and Functional Recovery After MI
increased risk of adverse outcome. Moreover, survivors of
PTCA for acute coronary syndrome had lower CTFC than
patients who died after PTCA (18). In this study, we clearly
demonstrated that CTFC predicted the degree of functional
recovery of the reperfused myocardium immediately after
TIMI 3 reperfusion without residual coronary stenosis
(percent diameter stenosis ,50%). The CTFC may provide
additional information about the degree of microcirculatory
damage in patients with TIMI 3 reperfused AMI. Thus,
CTFC at the time of reperfusion may enable identification
of patients who would benefit from additional pharmaco-
logical adjunctive treatment, which attenuates microvascular
dysfunction and augments myocardial blood flow in the
reperfused myocardium, such as verapamil, nicorandil and
adenosine (19–21). However, others were unable to dem-
onstrate the relationship between CTFC and adverse clin-
ical outcome or functional recovery after thrombolytic
therapy (22,23). These previous studies included patients
with TIMI 2 after a reperfusion procedure, which is
regarded as reperfusion failure in AMI (24,25). Further-
more, two different types of phasic coronary flow are
included in TIMI 2 flow: residual coronary stenosis and
microvascular damage (26). Therefore, the discrepancy of
these results may have been due to inclusion of TIMI 2
patients. Other explanations as to the reason for discrepan-
cies in outcome may be based on methodological problems
(27). Bhatt et al. (23) assessed flow to the distal circulation
in addition to the CTFC landmark. If a more distal
landmark was used, the variability in arterial length between
patients would have affected CTFC, and a more distal
landmark may incorporate an element of washout in the
measurement (27).
Reactive hyperemic response to reperfusion. Experimen-
tal studies have reported that flow to the risk area remains
hyperemic or comparable to that in the nonischemic bed up
to several hours after reperfusion (28–30). Heynderickx et
al. (28) found that functional recovery of the infarcted
myocardium was accompanied by marked increase in blood
flow to the infarcted bed shortly after reperfusion. In a
clinical setting, patients with CTFC ,14 (TIMI flow grade
4) after thrombolysis or PTCA were reported to have
excellent outcome (13). In this study, the degree of reactive
hyperemic response after reperfusion assessed by CTFC
predicted the degree of functional recovery of the reperfused
myocardium; lack of reactive hyperemic response after
reperfusion was associated with a delay in the recovery of
LV function due to microvascular damages of the infarcted
myocardium. Thus, not all TIMI flow grade 3 is created
equally, even after successful primary PTCA; and CTFC
may be used as a guide for the selection of newer revascu-
larization strategies or pharmacological adjunctive treatment
beyond TIMI flow grade 3 in patients with AMI.
Study limitations. Several limitations of this study should
be addressed. The CTFC is affected by residual coronary
stenosis, but none of our patients had significant residual
stenosis in the IRA as assessed by quantitative angiographic
analysis after PTCA. Although we did not confirm the
lumen cross-sectional area by intravascular ultrasound, there
may be a limitation of lumen enlargement despite satisfac-
tory lumen enlargement by the angiogram (31). Second,
cardiac enzyme was not evaluated to estimate the infarct
size. In addition to methodological problems and small
sample size, the course of cardiac enzyme release may also be
interfered with by hyperemic response, which makes the
enzymatic assessment difficult to estimate the infarct size.
Third, ST-segment resolution on ECG 1 h after the
reperfusion is also known as a simple prognostic parameter
after reperfused AMI (22,32). Although we did not make
any comparison between ST-segment resolution on ECG
and CTFC as a prognostic parameter, CTFC at the time of
reperfusion can be used as a predictor in the earlier phase of
AMI. Finally, we regarded the TIMI fast flow as a reactive
hyperemia. Several factors have been reported as determi-
nants of the reperfused coronary flow velocity, including
viscosity of blood (33,34), preload, afterload (35) and the
extent of the reperfusion injury (5). Since we made no
attempt to measure blood viscosity and the LV end-diastolic
pressure at the time of reperfusion, CTFC in our results
cannot be directly applied to the absolute microvascular flow
to the infarcted myocardium. However, our findings have
relevance to the net results of coronary flow to the infarcted
myocardium, including these factors. Further CTFC studies
are required for a more complete understanding of the
physiologic impact of these factors on coronary circulation
in patients with reperfused myocardial infarction.
Conclusions. The CTFC may be used to identify the
high-risk group after AMI at the time of reperfusion in
patients with AMI beyond TIMI flow grade 3. Absence of














Constant 1.78075 0.3045 0.1535 0
Elapsed time (h) 20.0325 0.0287 0.0145 20.1662 0.027
Collateral (grade $ 2) (%) 0.0881 0.0979 0.0494 0.1325 0.077
TIMI before PTCA (0/1/2) 0.2088 0.1124 0.0567 0.2801 ,0.001
CTFC (frames) 20.0340 0.0101 0.0051 20.5110 ,0.0001
Variables with p . 0.2 are not presented.
CTFC 5 corrected TIMI frame count; Elapsed time 5 from symptom onset to reperfusion; PTCA 5 percutaneous
transluminal coronary angioplasty; TIMI 5 Thrombolysis In Myocardial Infarction.
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reactive hyperemic response after reperfusion, high CTFC,
was associated with poor functional recovery and outcome.
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